Veradigm inc. announces that nasdaq hearings panel has granted its continued listing, pending return to compliance with nasdaq filing requirements

Chicago--(business wire)-- #healthit--veradigm inc. (nasdaq: mdrx (the “company”)) announced today that it received a decision from the nasdaq hearings panel (the “panel”) granting its request for continued listing on the nasdaq capital market, subject to the company demonstrating compliance with nasdaq listing rule 5250(c)(1) (the “listing rules”) on or before february 27, 2024, and certain other conditions, including the achievement of various interim milestones (the “panel decision”). as previously disc.
MDRX Ratings Summary
MDRX Quant Ranking